Company intelligence / Profile preview
Yatai Pharmaceutical
Shaoxing, Zhejiang, China
- Ownership
- Private
- Employees
- ~529
- Development stage
- Commercial
01
Overview
Zhejiang Yatai Pharmaceutical researches, manufactures, sells, and exports pharmaceutical products including solid dosage forms and injectable drugs. The company has both commercialized generic drugs and an early-stage R&D pipeline focused on metabolic diseases and oncology. It also participates in vaccine development through its group structure. Clinical results for new chemical entities are limited to preclinical or IND stages at present.
- Therapeutic areas
- Metabolic DisordersPulmonologyOncologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Yatai Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yatai Pharmaceutical.